161 related articles for article (PubMed ID: 27531721)
1. Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example.
Sekula P; Pressler JB; Sauerbrei W; Goebell PJ; Schmitz-Dräger BJ
BMJ Open; 2016 Aug; 6(8):e009972. PubMed ID: 27531721
[TBL] [Abstract][Full Text] [Related]
2. p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?
Schmitz-Dräger BJ; Goebell PJ; Ebert T; Fradet Y
Eur Urol; 2000 Dec; 38(6):691-9;discussion 700. PubMed ID: 11111186
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic importance of the immunohistochemical study of protein p53 in transitional-cell bladder tumors].
Gaĭyrov AG; Romanenko AM; Klimenko IA; Sakalo VS; Grigorenko VN; Nepomniashchiĭ VN
Lik Sprava; 1998; (5):86-9. PubMed ID: 9793315
[TBL] [Abstract][Full Text] [Related]
4. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
[TBL] [Abstract][Full Text] [Related]
6. [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].
Soukup V; Babjuk M; Dusková J; Pesl M; Szakácsova M; Zámefnik L; Dvorácek J
Cas Lek Cesk; 2007; 146(1):63-7. PubMed ID: 17310587
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
8. Significance of protein p53 overexpression in the clinical course of high-risk superficial bladder cancer.
Gil P; Allepuz C; Blas M; Borque A; del Agua C; Plaza L; Rioja LA
Urol Int; 2003; 70(3):172-7. PubMed ID: 12660452
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder.
Dekairelle AF; Tombal B; Cosyns JP; Gala JL
Clin Cancer Res; 2005 Jul; 11(13):4724-32. PubMed ID: 16000567
[TBL] [Abstract][Full Text] [Related]
10. [Expression of protein p53 in superficial transitional carcinoma of the bladder with differing course].
Rebassa Llull M; Gutiérrez Sanz-Gadea C; Muñoz Vélez D; Esteva Bauzá M; Gómez Bellvert C; Mus Malleu A; Riera Marí V; Hidalgo Pardo F; Torrens Darder I; Ozonas Moragues M
Arch Esp Urol; 1999 Dec; 52(10):1061-4. PubMed ID: 10680229
[TBL] [Abstract][Full Text] [Related]
11. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
[TBL] [Abstract][Full Text] [Related]
12. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.
Cordon-Cardo C; Zhang ZF; Dalbagni G; Drobnjak M; Charytonowicz E; Hu SX; Xu HJ; Reuter VE; Benedict WF
Cancer Res; 1997 Apr; 57(7):1217-21. PubMed ID: 9102201
[TBL] [Abstract][Full Text] [Related]
13. p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant.
Hodgson A; Xu B; Downes MR
Histopathology; 2017 Aug; 71(2):296-304. PubMed ID: 28342221
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation.
Cheng HL; Trink B; Tzai TS; Liu HS; Chan SH; Ho CL; Sidransky D; Chow NH
J Clin Oncol; 2002 Mar; 20(6):1544-50. PubMed ID: 11896103
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H
Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
Mahnken A; Kausch I; Feller AC; Krüger S
Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
[TBL] [Abstract][Full Text] [Related]
18. p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder.
Fleshner N; Kapusta L; Ezer D; Herschorn S; Klotz L
J Urol; 2000 Oct; 164(4):1177-82. PubMed ID: 10992361
[TBL] [Abstract][Full Text] [Related]
19. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
[TBL] [Abstract][Full Text] [Related]
20. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
